Xingjuan (Jane) Chao
About Xingjuan (Jane) Chao
Xingjuan (Jane) Chao is the Co-founder and Chief Executive Officer of Ceribell, where she has worked since 2014. She has held various strategic roles in organizations such as Novartis, Genentech, and McKinsey, and has an extensive academic background in biophysics, chemistry, and cinematography.
Work at Ceribell
Xingjuan Chao serves as the Co-founder and Chief Executive Officer of Ceribell, a position she has held since 2014. Under her leadership, the company has focused on developing innovative solutions in the medical field. Ceribell operates from Palo Alto, California, and emphasizes advancements in patient care and technology integration.
Previous Experience at Novartis
Before her current role, Xingjuan Chao worked at Novartis as a Senior Strategy Manager from 2013 to 2014. During her tenure in Basel, Switzerland, she contributed to strategic initiatives within the organization, leveraging her background in biophysics and management.
Background in Program Management
Xingjuan Chao has experience as a Program Officer at ClimateWorks Foundation from 2009 to 2010. This role involved managing programs aimed at addressing climate change, showcasing her commitment to environmental issues and strategic program development.
Education and Expertise
Xingjuan Chao's academic background includes a Postdoctoral fellowship at the University of California, San Francisco, completed in 2007. She holds a PhD in Biophysics from Cornell University, obtained in 2005, and a B.S. in Chemistry from Peking University, earned in 2001. Additionally, she studied Cinematography and Directing at the Beijing Film Academy from 2005 to 2006.
Career at McKinsey
Xingjuan Chao worked at McKinsey as an Engagement Manager from 2007 to 2013. Her six years at the firm involved consulting on various strategic projects, allowing her to develop a strong foundation in management and strategy.